+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Women's Health Diagnostics Market by Type, Application, End-User - Global Forecast 2025-2030- Product Image
Women's Health Diagnostics Market by Type, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Women's Health Diagnostics Market by Type, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4829897
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Women’s Health Diagnostics Market grew from USD 43.36 billion in 2023 to USD 46.82 billion in 2024. It is expected to continue growing at a CAGR of 9.25%, reaching USD 80.59 billion by 2030.

Women's health diagnostics encompass a range of medical tests and procedures aimed at identifying health conditions unique to women, including reproductive health issues, breast cancer, osteoporosis, and more. The necessity for such diagnostics arises from the increasing awareness about women's health, the rising prevalence of gynecological disorders, and demographic shifts like the aging female population. Application areas include clinical settings, home diagnostics, and research laboratories, with important end-use sectors being hospitals, diagnostic laboratories, and home healthcare solutions. Market growth is propelled by technological advancements in diagnostic tools, increasing healthcare expenditures, and initiatives for early disease detection. Additionally, the push for personalized medicine and patient-centered care is providing substantial momentum. However, challenges such as high diagnostic costs, limited access to healthcare in underdeveloped regions, and sociocultural barriers may impede market expansion. There is significant opportunity for innovation, particularly in the development of non-invasive, cost-effective diagnostic technologies and telemedicine solutions that enhance accessibility. Companies should also look into data analytics to personalize diagnostics and track patient outcomes more effectively.

Furthermore, partnerships and collaborations with emerging market players and investments in R&D for advanced diagnostics offer strategic advantages. Policy support for women's healthcare programs presents an additional avenue for growth. However, compliance with stringent regulatory requirements and maintaining data privacy in digital health solutions remain challenging. The market is highly competitive, characterized by rapid technological changes and the need for constant innovation. Areas ripe for research include biomarkers for early disease detection, AI integration for predictive diagnostics, and portable diagnostic devices. With women's health assuming higher priority on global health agendas, players in this sector should focus on offering comprehensive, accessible, and personalized diagnostic solutions while navigating the complex regulatory landscape and addressing the disparities in healthcare access.

Understanding Market Dynamics in the Women’s Health Diagnostics Market

The Women’s Health Diagnostics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing incantaces of chronic and life-style related disorders in women
    • Rising number of imaging and diagnostic centres across the globe
    • Improved and technically advanced healthcare infastructure
  • Market Restraints
    • High cost associated with procedure and diagnostic imaging system
  • Market Opportunities
    • Substantial focus on microfluidics and nanotechnology-based POC devices for diagnostic
    • Promising digital technology trends shaping women's health diagnostic
  • Market Challenges
    • Dearth of technically skilled healthcare professionals

Exploring Porter’s Five Forces for the Women’s Health Diagnostics Market

Porter’s Five Forces framework further strengthens the insights of the Women’s Health Diagnostics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Women’s Health Diagnostics Market

External macro-environmental factors deeply influence the performance of the Women’s Health Diagnostics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Women’s Health Diagnostics Market

The Women’s Health Diagnostics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Women’s Health Diagnostics Market

The Women’s Health Diagnostics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Women’s Health Diagnostics Market

The Women’s Health Diagnostics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Women’s Health Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuBioTech Co., Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomérieux SA, Cardinal Health, Inc., Carestream Health, Inc., Chembio Diagnostic Systems, Inc., Cook Medical, Inc., Danaher Corporation, DIALAB GmbH, EKF Diagnostics Holdings PLC, F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, GE Healthcare, Guided Therapeutics, Inc., Hill-Rom Holdings, Inc., Hologic, Inc., Koninklijke Philips N.V., MedGyn Products, Inc., NeuroLogica Corporation, Nova Biomedical, OSI Systems, Inc., Perkinelmer Inc., Quest Diagnostics Incorporated, Sekisui Diagnostics, LLC, Siemens AG, SuperSonic Imagine, Thermo Fisher Scientific Inc., and Werfen, S.A..

Market Segmentation & Coverage

This research report categorizes the Women’s Health Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Point-of-Care
    • Self Check
  • Application
    • Breast Cancer Testing
      • Biopsies
      • Blood Chemistries & Blood Cell Count Tests
      • Breast Cancer Tumor Marker Tests
      • Mammography
    • Cervical Cancer Testing
      • HPV Testing
      • PAP Smear
    • Infectious Disease Testing
      • HEPAtitis Testing
      • MRSA Testing
      • Tuberculosis Testing
      • Urinary Tract Infection Testing (Vaginal pH & Vaginitis)
    • Osteoporosis Testing
      • Bone Densitometry
      • in Vitro Blood Tests
    • Ovarian Cancer Testing
      • Diagnostic Imaging Tests
      • Ovarian Cancer Tumor Marker Tests
    • Pregnancy & Fertility Testing
      • Fertility Monitors
      • Lab-Based Testing
      • Pregnancy Testing & Ovulation Prediction Kits
    • Prenatal Genetic Screening & Carrier Testing
      • Cystic Fibrosis
      • Down Syndrome & Edwards Syndrome
      • Torch Infections
    • Sexually Transmitted Disease Testing
      • Chlamydia Trachomatis & Neisseria Gonorrhoeae (CT/NG) Testing
      • HIV Testing
    • Ultrasound Tests
      • Breast Imaging
      • OB/GYN Imaging
  • End-User
    • Diagnostic & Imaging Centers
    • Home Care
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incantaces of chronic and life-style related disorders in women
5.1.1.2. Rising number of imaging and diagnostic centres across the globe
5.1.1.3. Improved and technically advanced healthcare infastructure
5.1.2. Restraints
5.1.2.1. High cost associated with procedure and diagnostic imaging system
5.1.3. Opportunities
5.1.3.1. Substantial focus on microfluidics and nanotechnology-based POC devices for diagnostic
5.1.3.2. Promising digital technology trends shaping women's health diagnostic
5.1.4. Challenges
5.1.4.1. Dearth of technically skilled healthcare professionals
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Women’s Health Diagnostics Market, by Type
6.1. Introduction
6.2. Point-of-Care
6.3. Self Check
7. Women’s Health Diagnostics Market, by Application
7.1. Introduction
7.2. Breast Cancer Testing
7.2.1. Biopsies
7.2.2. Blood Chemistries & Blood Cell Count Tests
7.2.3. Breast Cancer Tumor Marker Tests
7.2.4. Mammography
7.3. Cervical Cancer Testing
7.3.1. HPV Testing
7.3.2. PAP Smear
7.4. Infectious Disease Testing
7.4.1. HEPAtitis Testing
7.4.2. MRSA Testing
7.4.3. Tuberculosis Testing
7.4.4. Urinary Tract Infection Testing (Vaginal pH & Vaginitis)
7.5. Osteoporosis Testing
7.5.1. Bone Densitometry
7.5.2. in Vitro Blood Tests
7.6. Ovarian Cancer Testing
7.6.1. Diagnostic Imaging Tests
7.6.2. Ovarian Cancer Tumor Marker Tests
7.7. Pregnancy & Fertility Testing
7.7.1. Fertility Monitors
7.7.2. Lab-Based Testing
7.7.3. Pregnancy Testing & Ovulation Prediction Kits
7.8. Prenatal Genetic Screening & Carrier Testing
7.8.1. Cystic Fibrosis
7.8.2. Down Syndrome & Edwards Syndrome
7.8.3. Torch Infections
7.9. Sexually Transmitted Disease Testing
7.9.1. Chlamydia Trachomatis & Neisseria Gonorrhoeae (CT/NG) Testing
7.9.2. HIV Testing
7.10. Ultrasound Tests
7.10.1. Breast Imaging
7.10.2. OB/GYN Imaging
8. Women’s Health Diagnostics Market, by End-User
8.1. Introduction
8.2. Diagnostic & Imaging Centers
8.3. Home Care
8.4. Hospitals & Clinics
9. Americas Women’s Health Diagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Women’s Health Diagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Women’s Health Diagnostics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. WOMEN’S HEALTH DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. WOMEN’S HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. WOMEN’S HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. WOMEN’S HEALTH DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. WOMEN’S HEALTH DIAGNOSTICS MARKET DYNAMICS
TABLE 7. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SELF CHECK, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOPSIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD CHEMISTRIES & BLOOD CELL COUNT TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TUMOR MARKER TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HPV TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PAP SMEAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HEPATITIS TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MRSA TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS), BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BONE DENSITOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IN VITRO BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TUMOR MARKER TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY FERTILITY MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY LAB-BASED TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING & OVULATION PREDICTION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DOWN SYNDROME & EDWARDS SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TORCH INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHOEAE (CT/NG) TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OB/GYN IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 97. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 98. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 99. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 100. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 101. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 102. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 103. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 104. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 105. CANADA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 109. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 110. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 111. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 112. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 113. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 114. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 115. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 116. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 117. MEXICO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 159. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 160. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 161. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 162. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 163. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 164. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 165. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 166. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 167. CHINA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 171. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 172. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 173. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 174. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 175. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 176. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 177. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 178. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 179. INDIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 183. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 184. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 195. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 196. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 197. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 198. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 199. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 200. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 201. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 202. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 203. JAPAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 207. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 208. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 209. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 210. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 211. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 212. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 217. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 219. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 220. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 221. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 222. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 223. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 224. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 225. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 226. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 227. PHILIPPINES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 231. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 232. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 233. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 234. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 235. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 236. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 237. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 238. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 239. SINGAPORE WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 243. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 244. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 245. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 246. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 247. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 248. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 249. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 250. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 251. SOUTH KOREA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 253. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 255. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 256. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 257. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 258. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 259. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 260. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 261. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 262. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 263. TAIWAN WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 264. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 265. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 267. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 268. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 269. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 270. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 271. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 272. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 273. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 274. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 275. THAILAND WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 276. VIETNAM WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 277. VIETNAM WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. VIETNAM WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 279. VIETNAM WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 280. VIETNAM WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 281. VIETNAM WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 282. VIETNAM WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 283. VIETNAM WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 284. VIETNAM WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 285. VIETNAM WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 286. VIETNAM WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 287. VIETNAM WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & F

Companies Mentioned

The leading players in the Women’s Health Diagnostics Market, which are profiled in this report, include:
  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomérieux SA
  • Cardinal Health, Inc.
  • Carestream Health, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Cook Medical, Inc.
  • Danaher Corporation
  • DIALAB GmbH
  • EKF Diagnostics Holdings PLC
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Guided Therapeutics, Inc.
  • Hill-Rom Holdings, Inc.
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • MedGyn Products, Inc.
  • NeuroLogica Corporation
  • Nova Biomedical
  • OSI Systems, Inc.
  • Perkinelmer Inc.
  • Quest Diagnostics Incorporated
  • Sekisui Diagnostics, LLC
  • Siemens AG
  • SuperSonic Imagine
  • Thermo Fisher Scientific Inc.
  • Werfen, S.A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 46.82 Billion
Forecasted Market Value ( USD ) by 2030 $ 80.59 Billion
Compound Annual Growth Rate9.2%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Womens Health Diagnostics Global Market Report 2024 - Product Image

Womens Health Diagnostics Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Women's Health Diagnostics Market Analysis & Forecast to 2024-2034 - Product Image

Women's Health Diagnostics Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Women's Health Diagnostics Market Report by Type, Application, End User, and Region 2024-2032 - Product Image

Women's Health Diagnostics Market Report by Type, Application, End User, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From
Women's Health Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Women's Health Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Women's Health Diagnostics - Global Strategic Business Report - Product Image

Women's Health Diagnostics - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From

About the Women Health Diagnostic Market

The Women Health Diagnostic market is a sector of the healthcare industry that focuses on the diagnosis and treatment of women's health issues. It includes a range of services, from preventive care to specialized treatments for conditions such as infertility, endometriosis, and menopause. Diagnostic tests are used to identify and monitor conditions, and treatments may include medications, lifestyle changes, and surgery. The market also includes products and services related to women's health, such as fertility tracking apps and hormone replacement therapy. The Women Health Diagnostic market is growing as more women seek out specialized care for their health needs. This growth is driven by increased awareness of women's health issues, improved access to healthcare, and advances in technology. Companies in the Women Health Diagnostic market include Athenahealth, Inc., Cerner Corporation, Epic Systems Corporation, and Allscripts Healthcare Solutions, Inc. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.